SEC Form 4 · accession 0001631746-15-000004
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chas McKhann
Officer — Chief Commercial Officer
Period of report
Feb 2, 2015
Accepted (ET)
Feb 3, 2015 · 5:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $21.26 | Feb 2, 2015 | A | 100,000 | A | — | Feb 1, 2025 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F125% of the shares subject to the option vest on February 2, 2016 and 1/48th of the shares subject to the option vest monthly thereafter over three (3) years.